PRESS RELEASE published on 04/02/2025 at 07:30, 8 months 3 days ago Inside Information / Other news releases Sensorion appoints Amit Munshi as Chairman of the Board and Independent Director, bringing extensive healthcare industry experience. Munshi to lead innovative therapeutic programs for hearing disorders Chairman Board Sensorion Amit Munshi Hearing Disorders
BRIEF published on 03/26/2025 at 07:35, 8 months 10 days ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 8 months 10 days ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
BRIEF published on 03/14/2025 at 07:35, 8 months 22 days ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 8 months 22 days ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 8 months 29 days ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 8 months 29 days ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
BRIEF published on 02/21/2025 at 07:35, 9 months 12 days ago Sensorion's SENS-501 Clinical Trial Progresses with Positive DMC Recommendation Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-501
PRESS RELEASE published on 02/21/2025 at 07:30, 9 months 12 days ago Inside Information / Other news releases Sensorion receives positive recommendation from Data Monitoring Committee for Audiogene Phase 1/2 clinical trial of SENS-501 gene therapy program to treat congenital deafness linked to OTOF gene mutations Gene Therapy Sensorion Audiogene Deafness Data Monitoring Committee
BRIEF published on 02/20/2025 at 07:35, 9 months 13 days ago Sensorion to Participate in March Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Loss Therapies March 2025
Published on 12/05/2025 at 02:35, 10 hours 27 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 2 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 57 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 2 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 57 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 2 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 2 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 48 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 2 hours 32 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 08:45, 4 hours 17 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 2 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 17 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 18 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
